Daily FNArena News

Michael Gable of Fairmont Equities suggests Whitehaven Coal may have seen a false break under the November low

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Tim Boreham reports Imagion’s CEO believes the oncology imaging innovator has achieved far more with its initial early-stage breast cancer study results than investors might appreciate.

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Despite consensus-beating earnings in the first half, brokers remain wary around pricing and costs for Boral

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Macquarie Group’s nine-month performance in FY23 to date has already topped the record profit in the same period last year, but brokers debate whether FY24 might be a different story

Drilling solutions company DDH1 has reported a record revenue half, with ongoing exploration spend in the sector set to sustain its outlook

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments